Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ISG15 Antikörper (AA 72-99)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch ISG15 in WB. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN387985

Kurzübersicht für ISG15 Antikörper (AA 72-99) (ABIN387985)

Target

Alle ISG15 Antikörper anzeigen
ISG15 (ISG15 Ubiquitin-Like Modifier (ISG15))

Reaktivität

  • 60
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 56
  • 7
  • 1
Kaninchen

Klonalität

  • 49
  • 15
Polyklonal

Konjugat

  • 44
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser ISG15 Antikörper ist unkonjugiert

Applikation

  • 48
  • 35
  • 28
  • 9
  • 8
  • 7
  • 5
  • 3
  • 2
  • 1
Western Blotting (WB)

Klon

RB15293
  • Bindungsspezifität

    • 7
    • 5
    • 5
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 72-99

    Aufreinigung

    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

    Immunogen

    This ISG15 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 72-99 amino acids from the Central region of human ISG15.

    Isotyp

    Ig Fraction
  • Applikationshinweise

    WB: 1:1000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

    Haltbarkeit

    6 months
  • Target

    ISG15 (ISG15 Ubiquitin-Like Modifier (ISG15))

    Andere Bezeichnung

    ISG15

    Hintergrund

    ISG15 is secreted from monocytes in response to type I interferons and causes natural killer (NK)-cell proliferation and an augmentation of non-MCH (major histocompatibility complex)-restricted cytotoxicity. Synthesis is stimulated by IFN-alpha or IFN-beta or IFN-omega , but not IFN-gamma . ISG15 expression is also induced by overexpression of interferon regulatory factors that participate in transcriptional regulation of IFN genes, and by influenza B virus. ISG15 is secreted also by cell lines of monocyte, T-lymphocyte, B-lymphocyte, human fibroblasts, and epithelial origins. The induction of terminal differentiation in human melanoma cells is associated with alterations in ISG15 expression. Enhancement of NK cell proliferation, augmentation of non-major histocompatibility complex-restricted cytotoxicity, and induction of IFN-gamma from T cells identify ISG15 as a member of the cytokine cascade and suggest that it may be responsible for amplifying and directing some of the immunomodulatory effects of IFN-alpha or IFN-beta. ISG15 has has also been shown to function intracellularly as a ubiquitin homolog.

    Molekulargewicht

    17888

    Gen-ID

    9636

    NCBI Accession

    NP_005092

    UniProt

    P05161
Sie sind hier:
Chat with us!